carbidopa has been researched along with Inappropriate GH Secretion Syndrome (Acromegaly) in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Camanni, F; Mantegazza, P; Massara, F; Molinatti, GM; Müller, EE; Picotti, GB | 1 |
| Shi, YF | 1 |
2 other study(ies) available for carbidopa and Inappropriate GH Secretion Syndrome (Acromegaly)
| Article | Year |
|---|---|
Carbidopa inhibits the growth hormone- and prolactin-suppressive effect of L-dopa in acromegalic patients.
Topics: Acromegaly; Adult; Carbidopa; Dopamine; Female; Growth Hormone; Humans; Kinetics; Levodopa; Male; Middle Aged; Prolactin; Thyrotropin | 1978 |
[Studies on the abnormal response of pituitary somatotropin to dopaminergic drugs in patients with acromegaly].
Topics: Acromegaly; Adenoma; Adult; Carbidopa; Dopamine; Female; Growth Hormone; Humans; Levodopa; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prospective Studies | 1990 |